Gut related inflammation and cardiorespiratory fitness in patients with CAD and type 2 diabetes: a sub-study of a randomized controlled trial on exercise training

Table 2 Physical performance and levels of gut leakage markers in all patients, and according to intervention groups at baseline

	All (n = 137)	Exercise (n = 52)	Control (n = 62)	p-values
Exercise time (min:sec)	8:23 ± 02:39	8:05 ± 02:23	8:47 ± 2:46	0.153
Maximal RER^a	1.17 (1.08, 1.23)	1.16 (1.04, 1.23)	1.16 (1.09, 1.23)	0.260
Maximal Borg rating scale (6–20)^a	17 (17, 19)	17 (17, 18)	18 (17, 19)	0.106
VO_2peak (mL/kg/min)	24.7 ± 5.9	24.4 ± 5.3	25.0 ± 6.6	0.556
VO_2peak (L/min)	2.17 ± 0.56	2.16 ± 0.52	2.18 ± 0.59	0.868
AT (mL/kg/min)	18.9 ± 4.1	18.9 ± 3.9	19.9 ± 4.6	0.263
AT (L/min)	1.68 ± 0.42	1.69 ± 0.36	1.75 ± 0.47	0.466
sCD14 (ng/mL)^a	1504 (1299, 1760)	1550 (1334, 1710)	1435 (1276, 1792)	0.456
LBP (µg/mL)^a	13.1 (10.3, 17.1)	12.7 (9.2, 15.8)	12.7 (10.6, 16.4)	0.562
I-FABP (pg/mL)^a	988 (783, 1497)	1004 (766, 1561)	971 (844, 1529)	0.891

Data are presented as mean ± SD if not stated otherwise
p-values are given for differences between the randomized groups. p-values < 0.05 were considered statistically significant.
RER Respiratory exchange rate, AT anaerobic threshold, VO_2peak Peak oxygen uptake
^aMedian (25, 75 percentiles)

ISSN: 1758-5996